Arthur Stem

Dr. Arthur Stem

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2023 in Environmental Pollution
Verified
Journal Article
Closed access
ASArthur Stem
Arthur Stem
KRKeegan L. Rogers
Keegan L. Rogers
JRJames R. Roede
James R. Roede
CRCarlos A. Roncal-Jimenez
Carlos A. Roncal-Jimenez
Richard J JohnsonRichard J Johnson
Richard J Johnson
Jared M. BrownJared M. Brown
Jared M. Brown

5 July 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PSPreston Stafford
Preston Stafford
SMSanchayita Mitra
Sanchayita Mitra
MDMargot Debot
Margot Debot
PLPatrick Lutz
Patrick Lutz
ASArthur Stem
Arthur Stem
MCMitchell J. Cohen
Mitchell J. Cohen
Blood Brain Barrier (BBB) breakdown is a secondary form of brain injury which has yet to be fully elucidated mechanistically. Existing research suggests that breakdown of tight junction proteins between endothelial cells is a primary driver of increased BBB permeability following injury, and intercellular signaling between primary cells of the neurovascular unit: endothelial cells, astrocytes, and pericytes; contribute to tight junction restoration. To expound upon this body of research, we analyzed the effects of severely injured patient plasma on each of the cell types in monoculture and together in a triculture model for the transcriptional and translational expression of the tight junction proteins Claudins 3 and 5, (CLDN3, CLDN5) and Zona Occludens 1 (ZO-1). Conditioned media transfer studies were performed to illuminate the cell type responsible for differential tight junction expression. Our data show that incubation with 5% human ex vivo severely injured patient plasma is sufficient to produce a differential response in endothelial cell tight junction mRNA and protein expression. Endothelial cells in monoculture produced a significant increase of CLDN3 and CLDN5 mRNA expression, (3.98 and 3.51 fold increase vs. control respectively, p<0.01) and CLDN5 protein expression, (2.58 fold change vs. control, p<0.01), whereas in triculture, this increase was attenuated. Our triculture model and conditioned media experiments suggest that conditioned media from astrocytes and pericytes and a triculture of astrocytes, pericytes and endothelial cells are sufficient in attenuating the transcriptional increases of tight junction proteins CLDN3 and CLDN5 observed in endothelial monocultures following incubation with severely injured trauma plasma. This data suggests that inhibitory molecular signals from astrocytes and pericytes contributes to prolonged BBB breakdown following injury via tight junction transcriptional and translational downregulation of CLDN5.

1 March 2024 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Closed access
CRCarlos A. Roncal-Jimenez
Carlos A. Roncal-Jimenez
KRKeegan L. Rogers
Keegan L. Rogers
ASArthur Stem
Arthur Stem
JWJulia Wijkstrom
Julia Wijkstrom
AWAnnika Wernerson
Annika Wernerson
Richard J JohnsonRichard J Johnson
Richard J Johnson
Silica nanoparticles found in sugarcane ash have been postulated to be a toxicant contributing to chronic kidney disease (CKD) of unknown etiology. However, although the administration of manufactured silica nanoparticles is known to cause chronic tubulointerstitial disease in rats, the effect of administering sugarcane ash on kidney pathology remains unknown. Here, we investigated whether sugarcane ash can induce CKD in rats. Sugarcane ash was administered for 13 wk into the nares of rats (5 mg/day for 5 days/wk), and blood, urine, and kidney tissues were collected at 13 wk (at the end of ash administration) and in a separate group of rats at 24 wk (11 wk after ash administration was stopped). Kidney histology was evaluated, and inflammation and fibrosis (collagen deposition) were measured. Sugarcane ash exposure led to the accumulation of silica in the kidneys, lungs, liver, and spleen of rats. Mild proteinuria developed, although renal function was largely maintained. However, biopsies showed focal glomeruli with segmental glomerulosclerosis as well as tubulointerstitial inflammation and fibrosis that tended to worsen even after the ash administration had been stopped. Staining for the lysosomal marker lysosomal associated membrane protein-1 showed decreased staining in ash-administered rats consistent with lysosomal activation. In conclusion, sugarcane ash containing silica nanoparticles can cause CKD in rats. NEW & NEWSWORTHY Epidemics of chronic kidney disease of unknown etiology have been reported in many areas of the world. In Central America, it occurs most commonly in sugarcane workers. Although heat stress is a major risk factor, there is some evidence that there may be a toxin. Here we show that sugarcane ash containing silica nanoparticles can induce chronic kidney disease in rats with similar features as observed in humans.

24 April 2026 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
ASArthur Stem
Arthur Stem
MAMohammad A M A E Alayyoub
Mohammad A M A E Alayyoub
RAReza Aalizadeh
Reza Aalizadeh
VNVarvara Nikolopoulou
Varvara Nikolopoulou
ALAthina Lisgara
Athina Lisgara
VVVasilis Vasiliou
Vasilis Vasiliou

4 September 2026 in Livers
Verified
Journal Article
Open access
PDF file
ASArthur Stem
Arthur Stem
ALAthina Lisgara
Athina Lisgara
MAMohammad A M A E Alayyoub
Mohammad A M A E Alayyoub
DBDomenica Berardi
Domenica Berardi
OAOladimeji Aladelokun
Oladimeji Aladelokun
VVVasilis Vasiliou
Vasilis Vasiliou
As metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-associated liver disease (ALD) grow increasingly prevalent, it is essential to improve understanding of the contributing factors and how these conditions may interact. Metabolic and alcohol-related liver injury frequently co-occur, prompting the introduction of the term metabolic dysfunction and alcohol-associated liver disease (MetALD) to describe individuals with MASLD who also consume significant amounts of alcohol. Among the exposures relevant to MetALD, dietary fructose is of particular interest because it shares multiple mechanisms of hepatotoxicity with alcohol. This review synthesizes current evidence for hepatotoxic interactions, emphasizing areas most relevant to MetALD pathogenesis. Epidemiologic data indicate substantial overlap between populations with high fructose and alcohol exposure, while clinical studies increasingly associate combined exposure with greater fibrosis progression and adverse liver outcomes. Several mechanistic pathways have been shown to overlap in terms of their interactions with fructose and ethanol, including endogenous fructose generation, cytochrome P450 2E1 (CYP2E1) induction, mitochondrial dysfunction, dysregulated lipid metabolism, uric acid-driven inflammasome signaling, and disruption of the gut–liver axis. Emerging evidence suggests that these pathways interact in ways that may amplify injury beyond the effects of either exposure alone. Greater integration of the alcohol and metabolic liver disease fields will be necessary to clarify mechanistic interactions, determine risk factors, and develop effective interventions for this increasingly common form of liver injury.